Bank of America’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.1K Sell
29,083
-2,992
-9% -$2.21K ﹤0.01% 5654
2025
Q4
$22.8K Sell
32,075
-9,923
-24% -$13.5K ﹤0.01% 6026
2025
Q3
$68K Sell
41,998
-10,857
-21% -$10.9K ﹤0.01% 6745
2025
Q2
$32.3K Sell
52,855
-40,839
-44% -$20.8K ﹤0.01% 6937
2025
Q1
$53.4K Sell
93,694
-53,764
-36% -$53K ﹤0.01% 6722
2024
Q4
$211K Sell
147,458
-10,958
-7% -$24.6K ﹤0.01% 6090
2024
Q3
$306K Buy
158,416
+32,730
+26% +$92.4K ﹤0.01% 5792
2024
Q2
$390K Sell
125,686
-100,183
-44% -$414K ﹤0.01% 5505
2024
Q1
$1.18M Buy
225,869
+77,068
+52% +$369K ﹤0.01% 4821
2023
Q4
$482K Buy
148,801
+82,886
+126% +$179K ﹤0.01% 5523
2023
Q3
$168K Buy
65,915
+22,531
+52% +$94.3K ﹤0.01% 5992
2023
Q2
$255K Sell
43,384
-26,724
-38% -$155K ﹤0.01% 5675
2023
Q1
$200K Sell
70,108
-7,948
-10% -$22.3K ﹤0.01% 5925
2022
Q4
$157K Buy
78,056
+52,459
+205% +$128K ﹤0.01% 6042
2022
Q3
$74K Buy
25,597
+7,941
+45% +$37.1K ﹤0.01% 6499
2022
Q2
$100K Sell
17,656
-649
-4% -$5.25K ﹤0.01% 6463
2022
Q1
$216K Buy
18,305
+3,566
+24% +$43.2K ﹤0.01% 6414
2021
Q4
$279K Buy
14,739
+13,704
+1,324% +$299K ﹤0.01% 6297
2021
Q3
$21K Buy
+1,035
New +$22.2K ﹤0.01% 7373

Other funds holding TNYA

Bank of America's TNYA Position: Q1 2026 in Review

Bank of America reduced its Tenaya Therapeutics (TNYA) stake by 9.3% in Q1 2026, selling an estimated $2.21K and leaving 29,083 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5654.

Bank of America first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.18M in Q1 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Bank of America held 29,083 shares of Tenaya Therapeutics worth $20.1K as of Q1 2026.
  • Bank of America sold 2,992 Tenaya Therapeutics shares in Q1 2026, an estimated $2.21K.
  • Tenaya Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5654 holding.
  • Bank of America first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Bank of America's Tenaya Therapeutics position peaked at $1.18M in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.